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Objectives: To discuss the relationship between the concentration of serum adipo-
nectin, interleukin-18 and the in-stent restenosis after percutaneous coronary inter-
vention procedure (PCI).
Methods: PCI procedure was carried out in 58 patients with coronary artery disease
in hospital. After the procedure,both coronary angiography and optical coherence
tomography (OCT) were conducted during follow-up period. Base on the coronary
angiography ﬁndings, in-stent restenosis (ISR) was conﬁrmed in 7 cases with a total
of 12 lesions (ISR group), while no in-stent restenosis (non-ISR) was seen in 51
cases with a total of 65 lesions (non-ISR group). The measurement indexes contain
the maximal neointimal hyperplasia thickness of stent, minimal lumen cross-
sectional area, stent cross-sectional area. And then we can calculate the neointimal
hyperplasia area, the percentage of the area of the neointimal, diameter stenosis ratio
and so on. Before and after the treatment, serum APN and IL-18 levels were
determined. The changes in serum APN and IL-18 levels after PCI in each group
were compared.
Results: Both the maximal neointimal hyperplasia thickness of stent and neointimal
hyperplasia area were signiﬁcantly larger, while the LA was signiﬁcantly smaller, in
ISR group than those in non-ISR group (P<0.05). Compared with patients without
restenosis and those with restenosis before PCI, the patients with coronary in-stent
restenosis showed signiﬁcantly increased serum IL-18 after PCI (P<0.05) and reduced
serum APN after PCI (P<0.05). In ISR group, the concentration of IL-18 before PCI
were obviously increased than that after PCI (P<0.05). In non-ISR group, the con-
centration of APN before PCI were obviously increased than that after PCI (P<0.05).
The percentage of the area of the neointimal was positively correlated to IL-18 and
inversely to serum APN.
Conclusions: After PCI the concentration of serum APN and IL-18 bear a close
relationship to the degree of restenosis.
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Objectives: In-stent restenosis (ISR) of drug eluting stent (DES) is currently one of
the most challenging situations in interventional cardiology since it is occurring with
increasing frequency. Recent studies found obvious morphological difference of tissue
characteristics between early (1 year after stenting) and late (>1 year after stenting)
ISR lesions. This study aimed to compare the efﬁciency of repeated DES for early and
late ISR of DES.
Methods: All patients undergoing repeated DES for ISR of DES in our hospital were
identiﬁed from October 2008 to December 2011, who were divided into early and late
ISR group according to ISR occurring within or more than 1 year after initial DES
implantation. Clinical target lesion revascularization (TLR) was the primary endpoint.
The secondary endpoint was major adverse cardiovascular events (MACE) including
all-cause death, myocardial infarction (MI) and TLR.
Results: Total 107 patients undergoing repeated DES for ISR of DES were identiﬁed
and enrolled in our study: 44 patients in early ISR group and 63 patients in late ISR
group. Overall TLR rate was 25.2 %. Early ISR group had higher TLR rate than late
ISR group (43.2% vs. 12.7%, P<0.001). MACE of early ISR group was higher than
that in late ISR group (47.73% vs. 15.87%, P< 0.001), which attributed to the sig-
niﬁcant difference of TLR between the two groups. Multivariable analysis found that
early ISR (Odds ratio (OR) ¼6.47, 95% Conﬁdence interval (CI): 2.262-18.504;
P< 0.001) was the only independent predictor of TLR during a median follow-up of
19.6 [11.4-22.0] months.
Conclusions: Repeated DES implantation is safe and efﬁcient for treatment of late
ISR of DES but is not appropriate for early ISR of DES.
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Objectives: This research of XTRM-FIT Coronary Stent System in combination with
Tiroﬁban in the treatment of 35 cases of elderly Acute Coronary Syndrome (ACS) had
a satisfactory result. The report is as follows:
Methods: Choose ACS 60 cases under PCI, according to random number table the
test was randomly divided into two groups: Group A (XTRM - FIT + Tiroﬁban) had
30 cases, male 16 cases, female 14 cases; Group B (XTRM - FIT) had 30 cases, male
15 cases, female 15 cases. Choose the same stent brand for each patient. There were
no statistically signiﬁcant in difference compared (P>0.05). According to the angi-
ography results of coronary artery stenosis degree, the degree of stenosis 75% was
deﬁned as PCI treatment lower limit. The size of stent was chose by clinical doctor.
After coronary artery guiding wire through Occlusion lesions, then give injection
load for Tiroﬁban 10 mg/kg, the intravenous injection is completed within 3 minutes.
For the 70-year-old or older patients or stroke patients within 2 years, the dosing is
reduced 20%, then the micro-injection pump continuous to inject 36h with 0.15
mg/(kg.min). In the process of PCI, intravenous injection heparin 50 U/kg, an extra
1000 U with each more than 1h.The presence of stenocardia, any abnormal changes
of electrocardiogram, myocardial enzyme, platelet count, hemoglobin, hematokritJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/C(HCT), etcoutpatient follow-up or telephone follow-up for 30 days about the inci-
dence of stenocardia, the incidence of subacute thrombosis, the rate of MACE,
rehospitalization rate. Using SPSS 10.0 statistical software for data processing.
P<0.05 for the difference was statistically signiﬁcant.
Results: In the two groups, there were no statistically signiﬁcant (P>0.05) for the
number of target vessel, Stenosis degree, the number of stent implantation, the Peak
pressure of stent release, operating time, PCI success rate, etc. The rate of acute in-
stent thrombosis occurred for the two groups were 0 and 3.33% respectively
(P<0.05).Bleeding complications: between the two groups (P>0.05).The platelet
count, hemoglobin, Hematokrit (HCT) change. Between the two groups (P>0.05).
30-day follow-up results after PCI: the rate of target vascular reconstruction, sub-
acute thrombosis, MACE rate and rehospitalization between the two groups
(P<0.05).
Conclusions: XTRM-FIT coronary stent system, is the latest generation coronary
artery stent which is manufactured by Blue Medical Devices B.V (the
Netherlands). It adopts unique “Dylyn” biological coating technology, reduces the
intravascular endothelial hyperplasia and inﬂammatory reaction. Short, both
XTRM-FIT Coronary Stent System in combination with Tiroﬁban and only stent
implantation all have good security, but have signiﬁcant differences for effec-
tiveness. For the combination therapy, the incidence of stenocardia, MACE rate,
the incidence of acute and subacute thrombosis and hospitalization rates, etc. were
signiﬁcantly lower.GW25-e2147
Impact of recombinant brain natriuretic peptide for prevention of contrast-
induced nephropathy in patients with chronic kidney disease undergoing
non-emergent percutaneous coronary intervention or coronary angiography
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Objectives: To investigate the effect of BNP for prevention of CIN in patients with
unstable angina (UA) and chronic kidney disease (CKD) undergoing elective percu-
taneous coronary intervention (PCI) or coronary angiography (CAG).
Methods: Patients with UA concomitant CKD (15ml/min/1.73 m2GFR60ml/
min/1.73m2) who would receive elective PCI or CAG were randomly assigned to
BNP group (0.005mg/kg/min within 24 hours before contrast media exposure in
addition to saline; n¼106) or the control group (only hydration with saline for 12h
before and 12h after procedure, n¼103). Cystatin C, serum creatinine (Scr) levels
and creatinine clearance rate (CCr) were collected before procedure, at 24h, 48h,1
week and 1 month after procedure. The primary outcome measure was the incidence
of CIN deﬁned by a relative (25%) or absolute (0.5 mg/dl; 44mmol/L) increase in
serum creatinine from baseline within 48 hours. The secondary endpoint was the
changes in the Scr, CCr and serum cystatin C concentrations before and after
procedure.
Results: Baseline characteristics of patients were similar for both groups. The
incidence of CIN was signiﬁcantly lower in patients on rhBNP infusion than those
on hydration (6.6% vs 16.5%, P<0.05). There was a more signiﬁcant deterioration
in the control group than in the BNP group of Ccr, Cystatin C and Scr from 48 hour
to 1 week (P<0.05). The CCr gradually deteriorated in both groups, but it was
lower and recovered faster in patients on rhBNP. Multivariate logistic regression
revealed the use of >100ml of contrast volume (odds ratio: 4.36; P¼0.004) and
BNP administration (odds ratio: 0.21; P¼0.006) to be independently predictive
of CIN.
Conclusions: In addition to hydration, exogenous administration of rhBNP before
contrast media exposure was effective in decreasing the incidence of CIN.GW25-e2164
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Objectives: To examine the safety and efﬁcacy of immediate rotational atherectomy
(RA) in nondilatable calciﬁed coronary lesions complicated by coronary dissection
during percutaneous coronary intervention (PCI).
Methods: One hundred and nighty-eight patients with severe coronary calciﬁcation
underwent PCI, and were randomized into immediate (n¼105) or delayed RA group
(n¼93) when coronary dissections occur.
Results: At a follow-up of 4 years, event-free survival rates were not statistically
different between the immediate and delayed RA group (81.9% vs 80.6%, P¼0.820).
Rates of PCI- and RA-related MACE and severe RA-related complications were not
statistically different between the two groups. Luminal loss was not signiﬁcantly
different between the immediate and delayed RA group as evaluated by quantitative
coronary angiography and IVUS. Two cases in the delayed RA group experienced
myocardial infarction during the 4-week waiting.
Conclusions: This study indicates that immediate rotational atherectomy (RA) during
percutaneous coronary intervention (PCI) is safe and effective in patients with coro-
nary artery dissection.ardiovascular Disease Clinical Research C149
